ExodusPoint Capital Management LP grew its position in TriMas Co. (NASDAQ:TRS - Free Report) by 28.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 103,724 shares of the industrial products company's stock after acquiring an additional 23,044 shares during the quarter. ExodusPoint Capital Management LP owned 0.26% of TriMas worth $2,551,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also modified their holdings of the company. Arrowstreet Capital Limited Partnership grew its position in TriMas by 38.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 255,560 shares of the industrial products company's stock worth $6,284,000 after acquiring an additional 71,088 shares in the last quarter. Norges Bank purchased a new position in shares of TriMas in the 4th quarter worth approximately $3,602,000. Vanguard Group Inc. increased its position in shares of TriMas by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 3,895,946 shares of the industrial products company's stock valued at $95,801,000 after purchasing an additional 82,068 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in TriMas during the 4th quarter valued at $202,000. Finally, American Century Companies Inc. boosted its stake in TriMas by 11.2% during the fourth quarter. American Century Companies Inc. now owns 78,876 shares of the industrial products company's stock worth $1,940,000 after buying an additional 7,938 shares during the period. 99.42% of the stock is owned by hedge funds and other institutional investors.
TriMas Stock Up 1.9 %
Shares of NASDAQ:TRS traded up $0.39 during trading on Friday, reaching $21.17. The stock had a trading volume of 178,514 shares, compared to its average volume of 304,016. The firm's 50-day simple moving average is $23.03 and its 200 day simple moving average is $24.70. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. TriMas Co. has a one year low of $19.33 and a one year high of $28.51. The company has a market capitalization of $861.96 million, a P/E ratio of 33.08 and a beta of 0.55.
TriMas Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 28th were given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend was Friday, February 28th. TriMas's payout ratio is presently 27.12%.
Insider Activity
In other news, Director Jeffrey A. Fielkow bought 2,500 shares of the business's stock in a transaction that occurred on Friday, February 28th. The shares were purchased at an average cost of $20.78 per share, with a total value of $51,950.00. Following the transaction, the director now directly owns 11,013 shares in the company, valued at approximately $228,850.14. The trade was a 29.37 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Scott A. Mell sold 2,218 shares of the firm's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $22.54, for a total value of $49,993.72. Following the completion of the transaction, the chief financial officer now owns 26,288 shares of the company's stock, valued at approximately $592,531.52. The trade was a 7.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders acquired 806,246 shares of company stock worth $19,338,213. Insiders own 1.10% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, BWS Financial reissued a "buy" rating and issued a $40.00 price objective on shares of TriMas in a research note on Friday, February 28th.
Read Our Latest Stock Report on TRS
TriMas Profile
(
Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Read More

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.